BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18410416)

  • 21. Drug exposure and psoriasis vulgaris: case-control and case-crossover studies.
    Cohen AD; Bonneh DY; Reuveni H; Vardy DA; Naggan L; Halevy S
    Acta Derm Venereol; 2005; 85(4):299-303. PubMed ID: 16191849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin use and risk of gallstone disease followed by cholecystectomy.
    Bodmer M; Brauchli YB; Krähenbühl S; Jick SS; Meier CR
    JAMA; 2009 Nov; 302(18):2001-7. PubMed ID: 19903921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term use of antihypertensive drugs and risk of cancer.
    Assimes TL; Elstein E; Langleben A; Suissa S
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of the association between carvedilol exposure and severe hypersensitivity reactions, angioedema, and anaphylactic reactions: a retrospective nested case-control analysis.
    Koro CE; Sowell MD; Stender M
    Clin Ther; 2012 Apr; 34(4):870-7. PubMed ID: 22444788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin and the risk of endometrial cancer: a case-control analysis.
    Becker C; Jick SS; Meier CR; Bodmer M
    Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.
    de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and risk factors for psoriasis in the general population.
    Huerta C; Rivero E; Rodríguez LA
    Arch Dermatol; 2007 Dec; 143(12):1559-65. PubMed ID: 18087008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blocking drugs and psoriasis. A review of cutaneous side effects and retrospective analysis of their effects on psoriasis.
    Gold MH; Holy AK; Roenigk HH
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):837-41. PubMed ID: 2903871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    J Am Geriatr Soc; 2012 May; 60(5):916-21. PubMed ID: 22458300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study.
    Horton DB; Scott FI; Haynes K; Putt ME; Rose CD; Lewis JD; Strom BL
    JAMA Dermatol; 2016 Feb; 152(2):191-9. PubMed ID: 26560335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasiform cutaneous eruptions induced by cetamolol hydrochloride.
    White WB; Schulman P; McCabe EJ
    Arch Dermatol; 1986 Aug; 122(8):857-8. PubMed ID: 2874772
    [No Abstract]   [Full Text] [Related]  

  • 33. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
    Shapiro J; Cohen AD; David M; Hodak E; Chodik G; Viner A; Kremer E; Heymann A
    J Am Acad Dermatol; 2007 Apr; 56(4):629-34. PubMed ID: 17157411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
    Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
    J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psoriasis and beta-blockade].
    Steinkraus V; Mensing H
    Hautarzt; 1992 Apr; 43(4):179-83. PubMed ID: 1350775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
    Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
    Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
    Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
    Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
    Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns.
    Nakhai-Pour HR; Rey E; Bérard A
    Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):147-54. PubMed ID: 20437474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of falls associated with antihypertensive medication: self-controlled case series.
    Gribbin J; Hubbard R; Gladman J; Smith C; Lewis S
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):879-84. PubMed ID: 21744415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.